Skip to content

The used of a curve needle to facilitate the lumbar sympathetic ganglion damage on treating with DPNP under the ultrasound guidance: a clinical randomized controlled study

The used of a curve needle to facilitate the lumbar sympathetic ganglion damage on treating with DPNP under the ultrasound guidance: a clinical randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063168
Enrollment
Unknown
Registered
2022-09-01
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DPNP(diabetic peripheral neuropathy pain)

Interventions

the curved-needle group:Ultrasound-guided bending needle lumbar sympathetic ganglion ablation for DPNP
the straight-needle group:Ultrasound-guided direct acupuncture lumbar sympathetic ganglion ablation for DPNP

Sponsors

Foshan Fosun Chancheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with diabetic peripheral neuropathy undergoing unilateral lumbar sympathetic ganglion destruction; 2. Aged from 18 to 80 years; 3. ASA II or III; 4. BMI 18 ~ 30 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung, liver, kidney and other diseases; 2. Severe diabetic complications, such as diabetic renal failure and diabetic heart disease; 3. The skin at the puncture site has ulceration, swelling, inflammation and infection; 4. Patients with abnormal coagulation function; 5. History of internal fixation after lumbar laminectomy or severe anatomic variation, such as scoliosis and tumor; 6. History of lumbar sympathetic neurochemistry or thermal lysis; 7. Pregnancy; 8. Those allergic to local anesthetics, anhydrous alcohol and iodohexyl injection; 9. Patients with mental illness or cognitive dysfunction caused by any reason who cannot cooperate to complete treatment evaluation or sign informed consent; 10. Patients who had received other treatment regimens for lumbar sympathetic ganglia 1 month before the study began.

Design outcomes

Primary

MeasureTime frame
Performance time;Success rate of damage;Imaging time;Number of needle redirections;

Countries

China

Contacts

Public ContactWang Meirong

Foshan Fosun Chancheng Hospital

wangmrong1217@163.com+86 13927241475

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026